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Abstract
Stem cells have recently attracted significant attention largely due to their potential therapeutic
properties, but also because of their role in tumorigenesis and their resemblance, in many aspects,
to cancerous cells. Understanding how stem cells are regulated, namely with respect to the control
of their proliferation and differentiation within a functional organism, is thus primordial to safely
profit from their therapeutic benefits. Here, we review recent advances in the understanding of
germline stem cell proliferation control by factors that respond to the nutritional status and/or
insulin signaling, through studies performed in C. elegans and Drosophila. Together, these data
uncover some shared fundamental features that underlie the central control of cellular proliferation
within a target stem cell population in an organism. These features may indeed be conserved in
higher organisms and may apply to various other stem cell populations.
Background
The development of multi-cellular organisms requires a
continual source of differentiating cells to populate fields
within diverse tissues. Similarly, following tissue damage,
the replacement of lost cells often relies on the prolifera-
tion and subsequent differentiation of a population of
pluripotent "stem" cells set aside from other cells within
this tissue. In order to maintain their population, stem
cells must self-renew at each division, which can be
accomplished through asymmetric division to generate
two different daughter cells – one that resembles the
mother (a stem cell), and one that is committed to
another differentiated fate. Alternatively the division can
result in the formation of two identical daughter cells that
are indistinguishable from the mother. This symmetric
mode of division enables stem cells to increase in num-
bers during development, or following an injury [1].
Stem cells occupy a specific microenvironment which is
referred to as the niche, wherein they receive the extrinsic
signals required to maintain their undifferentiated iden-
tity. These signals differ among the various stem cell types,
but their role in maintaining the stem cell population is
critical, and their expression defines the boundaries of the
niche [2].
The study of the regulation of the C. elegans, Drosophila,
and mouse Germline Stem Cell (GSC) populations during
development and adulthood has revealed a number of
important molecular mechanisms that govern the interac-
tions between stem cells and their niche [3]. Briefly, a
short-range signal(s) generated by the niche cell(s) – the
Distal Tip Cell (DTC) in C. elegans, the cap and hub cells
in the Drosophila ovary and testis, respectively, and the Ser-
toli cells in the mouse testis – prevents nearby GSCs from
differentiating. In fact, these extrinsic cues activate a
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molecular cascade within the GSCs that targets the activity
of specific transcription factors and/or translational regu-
lators, which in turn alter gene expression to specify and
maintain GSC identity.
Under optimal growth conditions, GSCs divide continu-
ously throughout development and adulthood, initially
to increase in numbers and later to provide a constant
supply of differentiating germ cells. Under these optimal
circumstances, the rate at which GSCs divide appears to be
primarily dependent on intrinsic factors and on their
interaction with the niche cell(s). In fact, signaling from
the niche cell(s) not only physically determines the size of
the GSC population, but also affects the rate at which
GSCs proliferate, depending on the level at which it regu-
lates GSC identity [4-6]. The limiting intrinsic factors are
very poorly defined, but recent advances suggest that the
timing of stem cell division may be regulated by a micro-
RNA-dependent down regulation of Dacapo, a p21/p27
Cyclin-Dependent Kinase (CDK) inhibitor, thereby relax-
ing controls on the G1/S transition [7]. That is, Drosophila
GSCs lacking dicer-1 (dcr-1) function, the loss of which
completely impairs microRNA processing, are delayed at
the G1/S boundary, and this delay is dependent on
Dacapo [8,9].
When environmental conditions are unfavorable to
growth however, the rate at which organisms develop is
delayed, owing to a general slowing in cell growth and
division. This likely occurs as a result of a direct lack of
critical nutrient resources required for macromolecular
synthesis, but also through nutrient sensing and the active
inhibition of energy consuming pathways, such as those
involved in cell growth and division, presumably to con-
serve limiting resources. Several intracellular and intercel-
lular molecular cascades play a role in this active response
to adverse growth conditions, including the insulin,
AMPK, and TOR signaling pathways [10-13]. It is there-
fore likely that the GSCs of starved animals follow similar
rules as the soma, and their growth/division rate may thus
be delayed under such conditions.
The GSCs contain the information that will be transmitted
from generation to generation, therefore their genetic
integrity is critical and must be guarded from deleterious
mutations. The precious treasure that they store is thus
subject to additional protective measures that are not uti-
lized in somatic cells. Consistent with this, it is now
widely accepted that transposon silencing mechanisms
operate much more efficiently in the germ line compared
to the soma to prevent deleterious effects caused by aber-
rant insertion and/or expression of sequences derived
from these elements [14]. In addition to transposition
events however, many other sub-optimal circumstances
may increase mutational susceptibility, including nutrient
deprivation [15]. It is therefore expected that under these
conditions, GSCs become quiescent in order to minimize
the risk of acquiring deleterious mutations due to driving
cell division during periods of insufficient energy or
resources to appropriately complete the cell cycle.
Nutrient stress blocks stem cell divisions
In most organisms examined to date, GSC divisions are
delayed when nutritional resources become limiting. For
example, sterols are essential for growth [16], but C. ele-
gans cannot synthesize them de novo, and instead must
metabolize exogenous sterols to meet this requirement.
When cholesterol levels are insufficient, the brood size of
C. elegans is markedly reduced due to a defect in germline
proliferation and differentiation [17]. This correlates with
a study that clearly demonstrated that female Drosophila
GSCs and their progeny uniformly adjust their prolifera-
tion rates in response to nutrition, such that no particular
developmental stage accumulates in the germarium of
poorly fed animals [18]. Therefore, GSCs must sense
nutrient quality and/or abundance, or alternatively they
must be capable of reading the general metabolic status of
the organism, to adjust their division rate accordingly.
Insulin signaling regulates the rate of GSC 
divisions
The general metabolic status of multi-cellular organisms is
monitored predominantly by insulin-like signaling [13].
In  C. elegans, encountering poor environmental condi-
tions during early post-embryonic life, including limited
nutritional resources and high population density, trig-
gers the entry into an alternative developmentally-sus-
pended stage called dauer, which is specialized for long-
term survival and dispersal. To understand how this
developmental switch is regulated, large-scale screens
have been carried out to isolate mutants that constitu-
tively enter dauer, or that are unable to execute this devel-
opmental switch [19,20]. Several highly conserved
components of insulin signaling have been identified
from these initial screens. That is, disrupting the function
of genes encoding positive components of the C. elegans
insulin-like cascade, such as the insulin-like growth factor
(IGF) receptor ortholog (daf-2) [21], the catalytic subunit
of PtdIns3-kinase (age-1) [22], the PtdInsP3-dependent
kinase (pdk-1) [23], or Akt/PKB (akt-1/2) [24] results in a
down regulation of the metabolic rate and induces consti-
tutive dauer arrest. In contrast, altering the function of
components that act antagonistically to the insulin-like
signaling cascade, including PtdIns3-phosphatase PTEN
(daf-18) [25], or the FOXO-like forkhead transcription
factor (daf-16) [26,27] disrupts the ability of animals to
enter dauer (Figure 1).
In animals in which the level of insulin-like signaling is
severely reduced, GSC divisions progressively slow downCell Division 2006, 1:29 http://www.celldiv.com/content/1/1/29
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during preparation for dauer [28], similar to what occurs
in somatic tissues, to finally completely arrest such that no
cell divisions occur during the dauer diapause. Similarly,
reducing insulin-like signaling later in life, following the
window of competence to execute dauer development has
been bypassed, also inhibits gamete production quite dra-
matically [29]. Therefore, the level of insulin-like signal-
ing somehow impinges, directly or indirectly, on the rate
at which GSCs divide.
In  Drosophila, insulin-like signaling also drastically
impinges on GSC division rate. In fact, while a homolog
of the vertebrate Insulin Receptor Substrate (IRS) 1–4,
CHICO, is required for female fertility [30], reduced activ-
ity of the Drosophila insulin receptor (dinr) specifically in
the GSCs strongly attenuates their rate of division [31].
Thus, the degree of activation of the insulin-like signaling
pathway, like the nutritional status, regulates the division
rate of GSCs. Furthermore, GSCs require dinr and chico to
Linking the insulin-like, AMPK and TOR signaling pathways upstream of GSC quiescence Figure 1
Linking the insulin-like, AMPK and TOR signaling pathways upstream of GSC quiescence. Upon insulin-like recep-
tor activation, PtdInsP3 kinase (PI3K) phosphorylates PtdInsP2. This activity is counteracted by PtdInsP3 phosphatase (DAF-18/
PTEN). PtdInsP3 activates, in a PDK-1/PDK1-dependent manner AKT/Akt, which phosphorylates and thereby prevents the 
nuclear translocation of the DAF-16/FOXO transcription factor. In Drosophila and mammals, Akt and AMPK act antagonistically 
to regulate TOR signaling through inhibitory and activating phosphorylation of TSC2, respectively. Arrows indicate activation; 
bars inhibition. Based on [11, 59, 85, 87, 88].Cell Division 2006, 1:29 http://www.celldiv.com/content/1/1/29
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properly adjust their division rate with nutrient availabil-
ity [18,31]. Therefore, nutrient depletion must impinge
on GSC divisions by reducing insulin-like signaling
within the GSCs, thereby inhibiting their proliferation
under these sub-optimal growth conditions.
Nutrients regulate GSC division rate through an 
insulin-dependent neuro-endocrine signal
In mammals, the insulin receptor is activated following its
association with an insulin molecule secreted by pancre-
atic β-cells in response to high blood sugar in order to
inhibit hepatic glucose production, while also stimulating
glucose uptake in muscles and adipose tissues [13]. The
insulin and insulin receptor superfamilies comprise sev-
eral members, including the insulin-like growth factors
(IGFs) and their receptors (IGFRs) among others, all of
which carry diverse functions [32]. In lower organisms
such as Drosophila and C. elegans however, there are sev-
eral insulin-like peptides that are mainly expressed in neu-
rons and either positively or negatively regulate the
activity of a unique insulin/IGF-1 receptor homolog
[33,34].
In Drosophila, there are seven insulin-like peptide (dilp1-7)
genes, all of which activate the single IGFR homolog
(dinr) and thereby promote growth [33,35]. In adult
females, DILPs are mainly expressed in two clusters of
neurosecretory cells in the brain [36], and the expression
of some of these is modulated by nutrient availability
[35]. Either the ablation of these DILP-producing cells or
the prevention of DILP secretion through impairment of
the Drosophila α-endosulfine (dendos) gene reproduce the
delay in GSC proliferation caused by the removal of the
dinr  gene specifically from the germ line [31,37].
Together, these results suggest that the nutritional status
regulates DILP expression in a collection of discrete head
neurons, and that these DILPs are secreted, transported,
and bind directly to DINR on the surface of the GSCs to
control their division rate in the Drosophila female.
In C. elegans, the pathway works somewhat differently.
There are 38 predicted insulin-like peptides that are also
predominantly expressed in the nervous system, some of
which antagonize and some of which activate the unique
insulin-like receptor homolog [34,38,39]. Experiments
designed to restore the function of the insulin-like recep-
tor (daf-2), PtdIns3-kinase (age-1), or of the downstream
target of the pathway, a FOXO-like forkhead transcription
factor (daf-16), in specific tissues have demonstrated that
daf-2 and age-1 activity in neurons is sufficient to sustain
reproductive development in daf-2 or age-1 mutant ani-
mals, respectively [40-42]. Furthermore, restoring daf-16
function specifically in the neurons of daf-16; daf-2 double
mutants, is sufficient to induce dauer development and
concomitantly block GSC divisions [[43], our unpub-
lished data]. It remains unclear, however, whether neuro-
nal daf-16 activity is similarly sufficient to couple GSC
proliferation with reduced insulin-like signaling levels in
a post-dauer situation. Furthermore, the nature of this
insulin-dependent neuro-endocrine signal that would
stimulate GSC divisions remains elusive. Part of a reason-
able hypothesis may be that elevated neuronal insulin-
like signaling levels influence the production of a sterol-
derived hormone by the cytochrome P450 DAF-9 in the
hypodermis and/or in a pair of neuroendocrine cells. This
hormone may in turn affect a nuclear hormone receptor
called DAF-12, thereby promoting reproductive develop-
ment [44-47]. However, other factors must be implicated
since daf-2; daf-12(0) double mutants, despite their ina-
bility to execute dauer and completely block GSC divi-
sions under reduced insulin-like signaling, grow into
sterile adults [46,48,49], indicating that insulin-like sign-
aling levels regulate GSC divisions and germline develop-
ment, at least in part, through a daf-12  independent
mechanism.
Insulin levels do not seem to affect niche-GSC 
signaling
A puzzling question remains whether this insulin-like-reg-
ulated signal also affects the manner with which the niche
communicates with the GSCs. In C. elegans and Drosophila
the niche is considered to actively promote proliferation
of the GSCs, while also inhibiting their differentiation [4-
6,50]. But during sub-optimal growth conditions it would
seem counterintuitive that the niche signal(s) would con-
tinue to stimulate proliferation of the GSCs while a sec-
ond signal would be required to inhibit them from
dividing in response to these environmental cues. In C.
elegans, a Delta/Serrate-like ligand called LAG-2, expressed
by the niche cell (DTC), activates a Notch receptor (GLP-
1) in the GSCs, thereby promoting their proliferation, as
opposed to their differentiation [50]. This cascade does
not seem to be affected by changes in insulin-like signal-
ing however, since both the ligand and the receptor con-
tinue to be expressed when insulin-like signaling is
reduced and GSCs become quiescent during dauer devel-
opment [28]. However, it is possible to reconcile these
observations if the niche signal(s) in fact does not directly
promote proliferation, but rather specifies GSC identity,
the fate of which is more prone to proliferation. It seems
logical that GSC identity must be maintained even when
these cells are not actively dividing.
PtdIns3-phosphatase PTEN regulates GSC 
divisions in a FOXO-independent manner
The PtdIns3-phosphatase PTEN acts downstream of the
insulin-like receptor in every organism examined thus far,
counteracting the activity of PtdIns3-kinase. Loss of PTEN
activity, therefore, results in increased PtdInsP3 levels, and
these increased levels are sufficient to completely suppressCell Division 2006, 1:29 http://www.celldiv.com/content/1/1/29
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all the phenotypes of insulin-like receptor mutants in C.
elegans and Drosophila [51,52]. These results suggest that
the effects observed due to variations in the activity of the
insulin-like receptor are mediated through its influence
on the abundance of PtdInsP3. Elevated PtdInsP3 levels
activate a complex that includes Akt/PKB in a PDK1-
dependent manner, which in turn phosphorylates and
thereby inhibits a FOXO forkhead transcription factor
from entering the nucleus (Figure 1) [53]. Although exper-
iments performed in mammalian cells identified other
Akt/PKB phosphorylation targets, including TSC2 in the
mTOR growth pathway [10,54,55], until very recently it
was believed that the activity of the C. elegans FOXO
homolog  daf-16  fully mediated the effects of reduced
insulin-like receptor (daf-2) activity, again because its
removal completely suppresses the effects of daf-2 muta-
tions on the development of this multi-cellular organism
[27,39]. However compelling evidence now demonstrates
that some daf-18/PTEN-dependent;  daf-16/FOXO-inde-
pendent regulation of GSC divisions occurs in C. elegans.
C. elegans hatchlings do not begin post-embryonic devel-
opment and their two initial GSCs do not proliferate until
the animals start feeding [56]. This quiescence of the GSCs
in starved L1 larvae requires the activity of daf-18/PTEN,
and the inappropriate divisions that occur in daf-18
mutants are suppressed by mutations in age-1/PtdIns3-
kinase or akt-1/Akt/PKB. In contrast, a daf-16/FOXO null
mutation does not bypass the food requirement for GSC
proliferation in starved L1 larvae [57]. Similarly, while
daf-18/PTEN is required in all circumstances to appropri-
ately down regulate the proliferation of the GSCs during
dauer development, daf-16/FOXO is almost fully dispen-
sable under certain conditions [28]. Moreover, both the
inhibition of the proliferation of normal GSCs in growing
larvae and of the tumorous GSCs in adult gld-1 mutants
provoked by reduced insulin-like receptor activity is not
completely suppressed by daf-16/FOXO null mutations
[28,58]. Together, these results suggest that reduced activ-
ity of the insulin-like receptor negatively regulates the rate
at which GSCs divide, at least in part, through FOXO-
independent PTEN and/or Akt/PKB targets.
Mysterious G2/M arrest of low insulin-induced 
quiescent GSCs
In mammalian cell culture, insulin signaling affects the
cell cycle machinery largely by regulating Akt/PKB activity,
which is required for progression through both G1/S and
G2/M checkpoints [59]. As previously mentioned, the tim-
ing of adult stem cell divisions appears to be mediated by
two G1/S regulators: p21 and p27 [7], while a large part of
the Akt/PKB-dependent G1/S regulation is believed to
occur through the regulation of these two CDK inhibitors
[59]. It seems plausible therefore that GSC quiescence in
organisms under nutrient stress occurs at the G1/S check-
point through the inhibition of Akt/PKB-dependent p21/
p27 down regulation. Consistent with this, RNAi deple-
tion of a C. elegans p21/p27 homolog (cki-1) induces GSC
hyperproliferation during dauer formation [60], but not
during early reproductive development, when nutrients
are not limiting [61], implicating it in GSC division con-
trol specifically during unfavorable growth conditions.
However, observations suggest that GSCs do not arrest in
G1, but rather at the G2/M checkpoint in starved/insulin-
like compromised C. elegans larvae. Namely, the quiescent
GSCs of dauer larvae have twice the DNA content of g1
arrested somatic cells [28]. Also, even when both p21/p27
CDK inhibitor homologs (cki-1 and cki-2) are depleted by
RNAi in starved L1 larvae, their GSCs do not divide [62].
Moreover, the GSCs of starved L1 animals have replicated
DNA content with condensed chromosomes and dupli-
cated centrosomes; centrosome duplication being specific
to S-phase [57]. Together, these data indicate that the
insulin-regulated quiescence of the GSCs occurs at the G2/
M checkpoint, at least in C. elegans, although G1-specific
CDK inhibitors may contribute to the deceleration of GSC
divisions associated with environmental stress.
It has been suggested that this surprising result may reflect
differences in the mechanisms of cell cycle regulation
when the cellular response is coordinated at the organis-
mal level, as opposed to within individual cells [63]. The
relevance or significance of this developmentally regu-
lated G2/M-arrest of GSCs in response to nutrient deple-
tion however remains unclear. Interestingly, mammalian
Embryonic Stem (ES) cells lack a G1checkpoint and
instead accumulate in S and G2 phases after irradiation, at
least in part, as a result of compromised Chk2 (a central
G1  checkpoint mediator) function. This difference
between somatic and ES cells has been proposed to con-
tribute to their reduced mutational frequencies, perhaps
through favoring the apoptosis of mutant cells over their
arrest and repair [64,65]. Consistent with this, a large pro-
portion of ES cells undergo apoptosis after treatment with
antimetabolite or genotoxic agents [64]. It is therefore
possible that the G2 arrest of GSCs in starved animals
favors the apoptotic elimination of those cells that have
accumulated mutations during the insult over their repair,
thereby preventing their transmission to the next genera-
tion.
The LKB1/AMPK cascade links GSC division rate 
with insulin levels
PTEN is an important tumor suppressor that is among the
most commonly mutated genes in most types of human
cancer. Also, germline PTEN mutations result in related,
dominantly inherited, cancer predisposing syndromes
[66]. The downstream targets of the insulin-regulated cas-
cade that couples GSC proliferation with nutritional sta-
tus are therefore of great interest, potentially representingCell Division 2006, 1:29 http://www.celldiv.com/content/1/1/29
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novel mediators of PTEN signaling that contribute to its
tumor suppressive properties.
A forward genetic approach in C. elegans identified aak-2
as a downstream effector that links GSC proliferation rate
with insulin-like signaling levels [28]. The screening strat-
egy took advantage of the developmentally-regulated
establishment of the complete GSC quiescence associated
with dauer development, such that dauer animals arrest
with a characteristic gonad size. Like in daf-18/PTEN
mutants, the germ line of aak-2 mutant dauers is hyper-
plasic. aak-2 encodes a homolog of the α2 catalytic subu-
nit of a heterotrimeric complex called AMP-activated
protein Kinase (AMPK) in humans. AMPK is best charac-
terized as an intracellular "metabolic master switch" that
turns OFF energy consuming pathways and turns ON
alternative energy producing pathways in response to an
increase in the AMP:ATP ratio, to restore energy balance
[12]. RNAi depletion of the other catalytic (α1) AMPK
subunit (aak-1) gives a phenotype that is similar to aak-
2(RNAi), while the inactivation of both subunits results in
significantly more pronounced germline hyperplasia,
indicating an additive function of the two catalytic AMPK
subunits [28].
In addition to being activated allosterically by AMP,
AMPK requires at least one key activating phosphoryla-
tion at a very conserved site to become fully catalytically
active [12]. The major AMPK-activating kinase was identi-
fied as LKB1/STK11 [67], a tumor suppressor that causes
cancer predisposition in humans [68,69]. As one might
predict, the inactivation of the C. elegans LKB1 homolog
(par-4) causes germline hyperplasia in dauer, with a sever-
ity similar to that of aak-1; aak-2 double mutants. Interest-
ingly, the requirement for aak-2  is cell autonomous,
suggesting that the LKB1-AMPK cascade functions within
the GSCs to regulate proliferation, likely in response to
the neuro-endocrine signal downstream of insulin-like
signaling [28]. This observation reveals the significance of
this LKB1-dependent AMPK phosphorylation in a devel-
oping animal, and suggests that the requirement for this
very highly conserved LKB1-AMPK cascade in insulin-
dependent regulation of GSC division rate may function
in other organisms, including humans.
Intensive biochemical studies, most of which were per-
formed in cultured cells, have identified a molecular cas-
cade that links both Akt/PKB and AMPK to the regulation
of the mTOR growth pathway. Briefly, Akt/PKB and AMPK
antagonistically regulate the activity of a TSC1-TSC2 com-
plex, another human tumor suppressor [70], through
direct phosphorylation of TSC2 [55,71-73], such that
when insulin signaling is elevated and the AMP:ATP ratio
is low, the TSC complex is antagonized by Akt/PKB, and is
not activated by AMPK. In turn, the TOR pathway is acti-
vated, thereby promoting protein synthesis and cell
growth (Figure 1) [11,74]. Interestingly, mutations in the
C. elegans TOR ortholog (let-363) cause larvae to arrest
with an underdeveloped germ line, although the animals
do not resemble dauer larvae [75]. Furthermore, TOR sig-
naling is required for vitellogenesis and egg development
in response to nutritional signals resulting from blood
ingestion in female mosquitoes [76]. Given that the rate
at which vitellogenesis proceeds is tightly coupled to that
of GSC proliferation and DILP signaling in Drosophila
[31,35], it is likely that TOR signaling couples GSC divi-
sion rate with nutrient status in insects. To date, however,
no direct evidence suggests the involvement of TOR sign-
aling in insulin-dependent regulation of GSC division
rate, although based on the biochemical and cellular
interactions described above, it is tempting to speculate
that the insulin-Akt/PKB and LKB1-AMPK cascades
together target TOR activity to adjust the rate of GSC divi-
sions according to the nutritional status of the organism.
The mechanisms at work in unicellular models and tissue
culture do not always reflect the complexity associated
with development typical of multi-cellular organisms,
and it will become a major challenge to account for all the
details that remain unanswered, particularly in C. elegans.
First, as previously mentioned, unlike in Drosophila, insu-
lin-like receptor activity is not required within the worm
germ line to sustain the robust GSC proliferation associ-
ated with reproductive development [41,42]. This sug-
gests that neural insulin-like peptides do not directly
control the rate of GSC divisions in this organism and
imply a second, yet uncharacterized, neuro-endocrine sig-
nal. Furthermore, the phenotypical and molecular links
between insulin-like and TOR signaling still lack experi-
mental support in this organism. That is, no obvious
TSC1/2 ortholog has been clearly identified in C. elegans,
while there are clear phenotypic differences between the
effects of mutations in these different pathways on devel-
opment, despite several commonalities, including growth
arrest [74,75]. Perhaps the most puzzling finding is the G2
arrest of quiescent GSCs, which does not fit with the
widely accepted view that nutrient depletion and TOR sig-
naling affect G1/S progression. That is, in yeast and mam-
malian cells, treatment with rapamycin (an inhibitor of
TOR signaling) induces G1 arrest [77-81]. It shall therefore
be a priority to determine whether this G2 arrest is an
exception or a rule in GSC regulation through a more
detailed examination of higher organisms, and whether
TOR signaling could somehow participate in this process.
Finally, genetic evidence suggests the involvement of
additional, yet unidentified genes linking insulin-like sig-
naling to the regulation of GSC divisions [28], and their
characterization may provide new insights into this cas-
cade.Cell Division 2006, 1:29 http://www.celldiv.com/content/1/1/29
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LKB1 was originally identified as an essential component
of polarity establishment in the C. elegans zygote, and in
the  Drosophila  oocyte and epithelium [82,83]. Further-
more, the artificial activation of LKB1 in mammalian
intestinal epithelial cells upon overexpression of its cofac-
tor STRAD induces their polarization and blocks their
division in culture [84]. In fact, LKB1 was shown to phos-
phorylate and activate several AMPK-related kinases,
including PAR-1/MARK and SAD/BRSK, both of which
play important roles in polarity establishment during
development [82,83,85,86]. It is however unclear whether
LKB1 contributes to the regulation of GSC divisions by
insulin-like signaling levels through its effects on cell
polarity.
Conclusion
In summary, evidence from C. elegans and Drosophila sug-
gest that the general nutritional status of an organism, as
reflected by the level of insulin-like signaling, regulates
the production of a neuro-endocrine signal that is
received by the GSCs and which dictates their division
rate. This neuro-endocrine signal may target the insulin
receptor itself (Drosophila), PTEN, and/or the LKB1-AMPK
cascade (C. elegans) within the GSCs to link their prolifer-
ation rate with insulin-like signaling level, at least in part,
in a FOXO-independent manner (C. elegans). Under the
conditions where insulin-like signaling is low enough to
completely block GSC divisions, the cells arrest at the G2/
M checkpoint, although this has not been confirmed in
Drosophila. These features may underlie the nutrient based
regulation of cell divisions in several types of stem cell
populations, and their better definition will be an impor-
tant priority to understand the key mechanisms that con-
trol their proliferative capacity, both in vivo and in vitro,
and whether cell or planar polarity is involved.
Whether the nutritional, insulin-dependent control of
GSC proliferation rate somehow relies on microRNA-
mediated control mechanisms is another important ques-
tion that should be addressed. Although this model has
been proposed [7], the two pathways may act in a com-
pletely parallel manner, as it seems to be the case regard-
ing the interplay between the niche and the specification
of GSC identity. Namely, no evidence involves microR-
NAs in insulin-like or nutrient-dependent regulation of
GSC division rate. A possible reflection of this may how-
ever underlie the germline hyperplasia of cki-1(RNAi) C.
elegans  dauer larvae, since this microRNA pathway is
believed to ultimately target a p21/p27 homolog.
Finally, GSCs share several features with most types of
cancer cells, including sustained proliferation, the rate of
which is sensitive to insulin signaling levels. Furthermore,
several related cancer-predisposing syndromes result
directly from germline mutations in central genes in the
pathways that seem to couple GSC proliferation with
organismal insulin signaling levels, including PTEN and
LKB1. The identification of the downstream targets in this
cascade will not only provide potential new candidates for
cancer therapy, but may also uncover some rationale
underlying the different characteristics of each of the can-
cer-predisposing syndromes associated with mutations in
these genes.
In the light of this discussion, one interesting possibility
that may account for some of the tumor suppressive
effects of PTEN and LKB1 is their function in preventing
division specifically when cells are more likely to acquire
mutations, during cell cycle progression under nutrient
depletion. Such mutant cells would therefore be predicted
to have a higher mutational rate, and may therefore rap-
idly gain a stronger proliferative advantage, or other char-
acteristics that affect key steps toward tumorigenesis.
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